Skip to main content

Interview Questions

Pharmaceutical Quality Assurance Interview Questions and Answers

Quality Assurance interviews rarely test definitions alone. Panels want to hear how you would contain a deviation on the shop floor, defend a CAPA effectiveness check, or explain an audit trail review to an inspector.

The questions below are drawn from the same bank used inside the AI Interview Simulator, with the model answer an evaluator would expect and the key points that earn marks.

10 questions with model answers · Updated for current GMP and ICH expectations

What this round covers

  • QMS and ICH Q10
  • Deviations and CAPA
  • Data integrity / ALCOA+
  • Change control
  • Audits and Form 483 responses

10 Quality Assurance interview questions with answers

  1. Q1QMSBeginner

    What is the primary objective of a Quality Assurance function in a pharmaceutical plant?

    Model answer: QA builds quality into the product by designing, governing and monitoring systems, not by testing quality in at the end.

    • Systems focus
    • Prevention over detection
    • Independent of production
  2. Q2ICHBeginner

    Which ICH guideline describes the Pharmaceutical Quality System?

    Model answer: ICH Q10 defines the PQS covering process performance, CAPA, change management and management review.

    • ICH Q10 elements
    • Lifecycle approach
    • Management responsibility
  3. Q3DeviationsBeginner

    A deviation is best defined as:

    Model answer: A deviation is an unplanned departure from an approved procedure, specification or standard that must be recorded, assessed and investigated.

    • Unplanned
    • Documented immediately
    • Impact assessment
  4. Q4DeviationsIntermediate

    What is the first step after a deviation is reported on the shop floor?

    Model answer: Contain the situation, secure product and evidence, then log the deviation within the timeline defined by SOP.

    • Containment
    • Timely logging
    • Evidence preservation
  5. Q5RCAIntermediate

    Which tool is most appropriate for structured root cause analysis of a recurring deviation?

    Model answer: Combining 5 Why with an Ishikawa (6M) diagram gives breadth of possible causes and depth on the true root cause.

    • 6M categories
    • Evidence at each Why
    • Documented conclusion
  6. Q6CAPAIntermediate

    CAPA effectiveness check should be:

    Model answer: Effectiveness checks are defined up front with objective acceptance criteria and reviewed after a stated period before final closure.

    • Predefined criteria
    • Defined monitoring period
    • Objective evidence
  7. Q7CAPAAdvanced

    Repeated deviations with the same root cause usually indicate:

    Model answer: Recurrence signals the earlier CAPA did not address the true root cause or was not sustained.

    • Recurrence trending
    • Re-open/escalate
    • Systemic fix
  8. Q8RegulatoryIntermediate

    Under 21 CFR 211, batch records must be reviewed and approved by:

    Model answer: The Quality Control Unit has the authority and responsibility to approve or reject all batch production records.

    • QCU authority
    • Independent review
    • Documented release
  9. Q9Data IntegrityBeginner

    What does ALCOA+ add to ALCOA?

    Model answer: ALCOA+ extends the core five attributes with Complete, Consistent, Enduring and Available.

    • Nine attributes
    • Applies to paper and electronic
    • Audit trail evidence
  10. Q10Data IntegrityIntermediate

    A shared analyst login on an HPLC workstation is a violation of:

    Model answer: Shared credentials break attributability because actions cannot be traced to a unique individual.

    • Unique user IDs
    • Role based access
    • Audit trail review

Rehearse these answers out loud

The remaining 88 Quality Assurance questions run inside the AI Interview Simulator, which adapts difficulty to your answers and scores your response against the same key points shown above. Creating a free account takes a minute — no card required.

Other pharma interview departments